Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

New Jersey to Host 21st BioPharma Clinical Trials Nexus

Solution providers and innovators of the pharma and healthcare industry, as well as experts in clinical trials, are invited to attend the 21st Biopharma Clinical Trials Nexus at the Holiday Inn Piscataway, Somerset, in New Jersey. This is an invite-only event that will be held from October 22, 2024, to October 23, 2024. BioPharma Nexus […]

GolfLync Inc. CEO and Co-Founder Noah DiPasquale is Dedicated to Offering Serious Golfers Epic Experiences and a Strong Community

GolfLync CEO and Co-Founder Noah DiPasquale, a visionary known for reimagining industries, is dedicated to providing an epic experience to all members of his exclusive Epic Golf Club, and now fostering a dynamic golfing community with GolfLync, a pioneering golf social networking platform where golf enthusiasts can come together and enjoy the game at its […]

Astiva Health Inc. Integrates Key Medicare Components into Single Plan, Making It Easier to Manage Healthcare, Access Resources

Over the past two decades, Medicare Advantage has transformed from a niche option into a primary choice for millions of seniors across the United States. Medicare Advantage plans bundle Part A, Part B and sometimes Part D coverage into one plan, along with often offering extra benefits that original Medicare doesn’t cover. A fast-growing Medical […]

D-Wave Quantum Inc. (NYSE: QBTS) Adds New Chief Human Resources Officer to Executive Management Team

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, recently announced the appointment of a new chief human resources officer to its executive team (https://ibn.fm/elbbu). The new chief human resources officer, Sophie Ames, brings more than 25 years of broad international experience […]

Annovis Bio Inc. (NYSE: ANVS) Seeking to Strengthen Intellectual Property Portfolio, Protecting Multifaceted Approach for Treatment of Neurodegenerative Diseases

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently filed three new patents (https://ibn.fm/wWksA). The patent applications seek protection for innovative combination therapies involving buntanetap that improve cognition beyond normal levels. Specifically, the patent filings cover buntanetap combined […]

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) Positioned to Become Dynamic Player in Renowned Malartic Mining Region

The region of Malartic, located in Quebec, Canada, is synonymous with gold mining. Since the early 20th century, Malartic has been a cornerstone of Canada’s mining industry, playing a pivotal role in the development of the province’s rich mineral resources. Renforth Resources (CSE: RFR) (OTCQB: RFHRF), a mineral exploration company engaged in the acquisition, exploration […]

Copper-Gold Mining Sector Set to Gain as Torr Metals Inc. (TSX.V: TMET) Announces $600K Private Placement Amid Interest Rate Cuts

As the Federal Reserve continues to take steps to lower interest rates, the mining sector, particularly copper and gold, is poised to benefit. Torr Metals Inc. (TSX.V: TMET) has taken advantage of this market environment by announcing a non-brokered private placement, seeking to raise up to $600,000 Canadian. The proceeds will be dedicated to the […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study

June 26, 2026

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Clinical studies are among the most demanding and consequential undertakings in medicine. They require years of planning, careful patient selection, rigorous data collection and ongoing regulatory oversight, all in pursuit of a single goal — generating reliable evidence that a […]

Rotate your device 90° to view site.